Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

13.02
-1.6100-11.00%
Post-market: 13.480.4608+3.54%19:59 EST
Volume:2.11M
Turnover:29.29M
Market Cap:72.79M
PE:-1.68
High:15.30
Open:14.60
Low:12.66
Close:14.63
Loading ...

Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs

TIPRANKS
·
03 Dec 2024

Tonix Pharmaceuticals Announces Expansion of Leadership Team With Two Strategic Hires

THOMSON REUTERS
·
03 Dec 2024

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

GlobeNewswire
·
03 Dec 2024

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Zacks Small Cap Research
·
03 Dec 2024

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

GlobeNewswire
·
26 Nov 2024

Top Premarket Gainers

MT Newswires Live
·
20 Nov 2024

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

GlobeNewswire
·
19 Nov 2024

Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects

TIPRANKS
·
18 Nov 2024

Press Release: Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Dow Jones
·
18 Nov 2024

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

ACCESSWIRE
·
14 Nov 2024

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire
·
14 Nov 2024

Tonix Pharmaceuticals announces publication of study on tolerability of TNX-801

TIPRANKS
·
13 Nov 2024

BRIEF-Tonix Pharmaceuticals Announces Peer-Reviewed Publication In Msphere Journal Highlighting The Tolerability Of Company’S Single-Dose Mpox And Smallpox Vaccine Candidate TNX-801, In Immune-Compromised Animals

Reuters
·
13 Nov 2024

Tonix Pharmaceuticals Holding Corp - Tnx-801 Tolerability in Immune-Compromised Animals Supports Clinical Development

THOMSON REUTERS
·
13 Nov 2024

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Msphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate Tnx-801, in Immune-Compromised Animals

THOMSON REUTERS
·
13 Nov 2024

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

GlobeNewswire
·
13 Nov 2024